US Industry Earnings Intelligence

Beverages - Non-Alcoholic earnings map

Forward reporting exposure, estimate delivery, earnings growth and company-level event concentration.

Forward window13 Oct to 11 Jan 202712 matched companies

Group read

Delivery and earnings growth are broadly constructive

70% of companies with measured latest results beat estimates, while 67% show positive year-on-year EPS growth. Consumer Defensive carries the largest forward market-cap exposure.

Forward events12next 90 days
Market-cap exposure$570.8Bmatched companies
Latest beat breadth70%latest measured quarter
Positive EPS growth67%year on year

Forward exposure

Beverages - Non-Alcoholic reporting load by date

Count and matched market cap

Delivery

Latest result breadth

70%beat breadth

Timing

Session certainty

83%estimate coverage

Growth breadth

Positive versus contracting

Company size

Capital at risk by tier

Company attention queue

Most consequential upcoming reports

Ordered by market capitalisation so the largest potential peer and index read-through appears first.

12 shown
KOThe Coca-Cola CompanyBeverages - Non-Alcoholic
27 Oct14 days
Event risk23/100Contained
Market cap$380.2BBefore the open
Beat rate100%up to 8 quarters
EPS growth17.5%year on year
Open earnings dossier
MNSTMonster Beverage CorpBeverages - Non-Alcoholic
5 Nov23 days
Event risk36/100Moderate
Market cap$83.9BTime unconfirmed
Beat rate63%up to 8 quarters
EPS growth35.2%year on year
Open earnings dossier
KDPKeurig Dr Pepper IncBeverages - Non-Alcoholic
3 Nov21 days
Event risk22/100Contained
Market cap$44.0BBefore the open
Beat rate63%up to 8 quarters
EPS growth-7.1%year on year
Open earnings dossier
KOFCoca-Cola Femsa SAB de CV ADRBeverages - Non-Alcoholic
27 Oct14 days
Event risk46/100Elevated
Market cap$23.0BBefore the open
Beat rate50%up to 8 quarters
EPS growth1.5%year on year
Open earnings dossier
COKECoca-Cola Consolidated Inc.Beverages - Non-Alcoholic
4 Nov22 days
Event risk24/100Contained
Market cap$12.5BTime unconfirmed
Beat rate-up to 8 quarters
EPS growth-6.1%year on year
Open earnings dossier
PRMBPrimo Brands CorporationBeverages - Non-Alcoholic
5 Nov23 days
Event risk36/100Moderate
Market cap$7.9BBefore the open
Beat rate63%up to 8 quarters
EPS growth-year on year
Open earnings dossier
CELHCelsius Holdings IncBeverages - Non-Alcoholic
5 Nov23 days
Event risk44/100Moderate
Market cap$7.5BTime unconfirmed
Beat rate38%up to 8 quarters
EPS growth-16.3%year on year
Open earnings dossier
AKO.BEmbotelladora Andina S.ABeverages - Non-Alcoholic
27 Oct14 days
Event risk35/100Moderate
Market cap$4.8BTime unconfirmed
Beat rate88%up to 8 quarters
EPS growth14.9%year on year
Open earnings dossier
AKO.AEmbotelladora Andina S.ABeverages - Non-Alcoholic
27 Oct14 days
Event risk47/100Elevated
Market cap$3.7BTime unconfirmed
Beat rate86%up to 8 quarters
EPS growth14.9%year on year
Open earnings dossier
COCOVita Coco Company IncBeverages - Non-Alcoholic
4 Nov22 days
Event risk44/100Moderate
Market cap$3.1BTime unconfirmed
Beat rate88%up to 8 quarters
EPS growth69.9%year on year
Open earnings dossier
ZVIAZevia PbcBeverages - Non-Alcoholic
4 Nov22 days
Event risk44/100Moderate
Market cap$96.7MTime unconfirmed
Beat rate75%up to 8 quarters
EPS growth-year on year
Open earnings dossier
BRFHBarfresh Food Group IncBeverages - Non-Alcoholic
5 Nov23 days
Event risk44/100Moderate
Market cap$19.9MTime unconfirmed
Beat rate13%up to 8 quarters
EPS growth-year on year
Open earnings dossier

Forward company tape

Beverages - Non-Alcoholic upcoming earnings reports

12 shown

Interpretation

How to read group earnings intelligence

Calendar concentration

Counts show operational density. Market-cap exposure identifies dates with greater potential for peer and index read-through.

Delivery breadth

Only the latest measured result per matched company enters the breadth split, preventing long-history companies from dominating.

Growth breadth

Positive year-on-year EPS growth is kept separate from estimate surprise because growth and expectations answer different questions.

Decision use

The page helps prioritise research and event risk. It does not determine whether to buy, sell or expect a directional reaction.

Evidence context